Securities code: 300143 securities abbreviation: Inkon Life Technology Co.Ltd(300143) Announcement No.: 2022-008
Inkon Life Technology Co.Ltd(300143)
Announcement on the report on public solicitation of entrusted voting rights by independent directors
Lu Jun, an independent director, guarantees that the information provided to the company is true, accurate and complete without false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the contents of the announcement are consistent with the information provided by the information disclosure obligor.
important clause
1. This solicitation of voting rights is a public solicitation according to law, and the soliciter Lu Jun meets the solicitation conditions specified in Article 90 of the securities law of the people’s Republic of China, Article 31 of the rules for the general meeting of shareholders of listed companies and Article 3 of the Interim Provisions on the administration of public solicitation of shareholders’ rights of listed companies;
2. The solicitor does not hold shares of the company.
According to the relevant provisions of the measures for the administration of equity incentive of listed companies (hereinafter referred to as the “measures”) of the China Securities Regulatory Commission (hereinafter referred to as the “CSRC”), Lu Jun, an independent director of Inkon Life Technology Co.Ltd(300143) (hereinafter referred to as the “company”), is entrusted by other independent directors as the collector, Solicit entrusted voting rights from all shareholders of the company on the relevant proposals of the company’s 2022 restricted stock incentive plan (hereinafter referred to as the “incentive plan”) to be considered at the first extraordinary general meeting of 2022 to be held on January 27, 2022.
China Securities Regulatory Commission, Shenzhen Stock Exchange and other government departments have not expressed any opinions on the authenticity, accuracy and completeness of the contents described in this report, and are not responsible for the contents of this report. Any statement to the contrary is a false statement.
1、 Statement of the collector
I, Lu Jun, as the soliciter, only solicit the shareholders’ entrusted voting rights for the relevant proposals of the company’s restricted stock incentive plan in 2022 to be considered at the first extraordinary general meeting of shareholders in 2022, and prepare and sign this report. The collector guarantees that there are no false records, misleading statements or major omissions in this collection report, and shall bear separate and joint legal liabilities for its authenticity, accuracy and completeness; We guarantee that we will not use this solicitation of voting rights to engage in securities fraud activities such as insider trading and market manipulation.
The solicitation of entrusted voting rights is publicly conducted free of charge. This report is on cninfo.com (www.cn. Info. Com. CN), an information disclosure website designated by the CSRC Make an announcement on the Internet. This solicitation is entirely based on the responsibilities of the soliciter as an independent director, and the information released is free of false and misleading statements. The soliciter has obtained the consent of other independent directors of the company and signed this report. The performance of this report will not violate or conflict with any provisions of laws and regulations, the articles of association or the company’s internal system. This report is only for the purpose of soliciting voting rights this time, and shall not be used for any other purpose. 2、 Basic information of the company and matters of this solicitation
1. Basic information of the company
Chinese Name: Inkon Life Technology Co.Ltd(300143)
English Name: inkon Life Technology Co., Ltd
Registered address: No. 37, Chunyang Road, Chengyang District, Qingdao, Shandong
Listing time: December 9, 2010
Listing place: Shenzhen Stock Exchange
Stock abbreviation: Inkon Life Technology Co.Ltd(300143)
Stock Code: 300143
Legal representative: Peng Wen
Secretary of the board of directors: Hu Yuanyuan
Office address: 6 / F, block a, Haier cloud Valley innovation building, No. 1, Haier Road, Laoshan District, Qingdao, Shandong Province
Postal Code: 266103
Tel: 0532-55776787
Fax: 0532-55776787
e-mail address: [email protected].
2. Solicitation matters
The collector shall publicly solicit the entrusted voting rights from all shareholders of the company for the following proposal considered at the first extraordinary general meeting of shareholders in 2022:
(1) Proposal on the company’s restricted stock incentive plan (Draft) in 2022 and its summary; (2) Proposal on the company’s measures for the assessment and management of the implementation of the restricted stock incentive plan in 2022; (3) Proposal on requesting the general meeting of shareholders to authorize the board of directors to handle matters related to the company’s equity incentive plan.
3、 Basic information of the general meeting of shareholders
For details on the convening of this general meeting, please refer to the company’s website cninfo.com (www.cn. Info. Com. CN.) designated by the CSRC for information disclosure Notice on convening the first extraordinary general meeting of shareholders in 2022.
4、 Basic information of the recruiter
1. The current independent director of the company, Mr. Lu Jun, is the person to solicit voting rights. His basic information is as follows: Lu Jun, male, born in September 1958, Chinese nationality, no permanent right of residence abroad, CPC member, master of business administration and senior economist. Mr. Lu Jun taught at the Second Military Medical University from March 1980 to August 1998, and successively served as general manager of China Meheco Group Co.Ltd(600056) Group Shanghai Likang Pharmaceutical Co., Ltd., general manager and chairman of Sinopharm holding Guoda pharmacy Co., Ltd. (founder of Guoda pharmacy) from August 1998 to November 2011. Mr. Lu Jun was also a director of Sinopharm Shanxi Co., Ltd., Sinopharm CICC (Shanghai) Medical Health Investment Management Co., Ltd., West China dental Co., Ltd., Sinopharm Sichuan Pharmaceutical Group Co., Ltd., Sinopharm holding Jiangsu Co., Ltd., Sinopharm holding tin free Co., Ltd., Sinopharm holding Anhui Co., Ltd., Sinopharm holding Changzhou Co., Ltd Chairman of Sinopharm Zhejiang Co., Ltd., Sinopharm Wenzhou Co., Ltd., Sinopharm Chemical Reagent Co., Ltd., Sinopharm Lingyun biomedical (Shanghai) Co., Ltd., Sinopharm Hutchison Whampoa Pharmaceutical (Shanghai) Co., Ltd. Mr. Lu Jun joined Sinopharm holdings in January 2003. From April 2003 to June 2004, he served as assistant general manager of Sinopharm holdings, general manager of drug retail business department and director of investment planning department; From June 2004 to October 2018, he has been the vice president of Sinopharm holdings, in charge of investment and other work. He has more than 44 years of working experience, including more than 20 years of management experience in the pharmaceutical and health care products industry. He is a senior professional in the industry. He joined SF DHL supply chain China in February 2019 and is currently the Chief Strategic Officer, general manager of life science and medical industry division, senior vice president and director of Greater China Management Committee; He has been an independent director of the company since May 2019.
2. As of the disclosure date of this announcement, the collector has not held shares of the company, has not been punished for securities violations, and has not involved in major civil litigation or arbitration related to economic disputes.
3. The collector and its main immediate family members have not reached any agreement or arrangement on matters related to the equity of the company; As an independent director of the company, he has no relationship with the company’s directors, senior managers, shareholders holding more than 5%, actual controllers and their affiliates, and there is no interest between the collector and the proposals involved in the solicitation of voting rights.
5、 Solicitors’ voting on solicitation matters
As an independent director of the company, the recruiter attended the 19th (Interim) meeting of the Fifth Board of directors held on January 11, 2022, He also voted in favor of the proposal on the company’s restricted stock incentive plan in 2022 (Draft) > and its summary, the proposal on the company’s measures for the implementation and assessment of the restricted stock incentive plan in 2022, and the proposal on submitting to the general meeting of shareholders to authorize the board of directors to handle matters related to the company’s equity incentive plan, and expressed independent opinions on the relevant proposals.
6、 Solicitation scheme
In accordance with the current laws, regulations, normative documents and the provisions of the articles of association of the company, the collector has formulated the scheme for the solicitation of voting rights. The specific contents are as follows:
(I) solicitation object: the shareholders of the company who have been registered in Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. and have gone through the registration procedures for attending the meeting after the transaction is completed in the afternoon of January 21, 2022.
(II) collection time: January 24, 2022 to January 25, 2022 (9:00-11:30 a.m. and 13:30-17:00 p.m.).
(III) collection method: it is publicly available on the information disclosure website designated by the CSRC (www.cn. Info. Com. CN.) An announcement was issued on the to solicit voting rights.
(IV) collection procedures and steps
Step 1: if the solicitation object decides to entrust the soliciter to vote, it shall fill in the power of attorney for public solicitation of voting rights of Inkon Life Technology Co.Ltd(300143) independent directors (hereinafter referred to as the “power of attorney”) item by item according to the format and content determined in the annex to this report.
Step 2: entrust the voting shareholders to submit the power of attorney and other relevant documents signed by them to the Securities Department of the company entrusted by the collector; The Securities Department of the company shall sign and receive the power of attorney and other relevant documents for the solicitation of entrusted voting rights:
1. If the entrusted voting shareholder is a legal person shareholder, it shall submit a copy of the legal person’s business license, the original identity certificate of the legal representative, the original power of attorney and the shareholder’s account card; All documents of the legal person shareholder in accordance with this article shall be signed page by page by the legal representative and stamped with the official seal of the shareholder unit;
2. If the entrusted voting shareholder is an individual shareholder, it shall submit a copy of its own ID card, the original power of attorney and the shareholder account card;
3. If the power of attorney is signed by another person authorized by the shareholder, the power of attorney shall be notarized by a notary organ and submitted together with the original power of attorney; The power of attorney signed by the shareholder himself or the legal representative of the shareholder unit does not need to be notarized;
Step 3: after the entrusted voting shareholders have prepared relevant documents according to the requirements of step 2 above, they shall deliver the power of attorney and relevant documents by personal delivery, registered letter or express mail within the collection time and at the address specified in this report; If registered mail or express mail is adopted, the time of receipt shall be subject to the time of receipt by the Securities Department of the company.
The designated address and addressee of the power of attorney and relevant documents delivered by the shareholders entrusted to vote are:
Address: 6 / F, tower a, Haier cloud Valley innovation building, No. 1, Haier Road, Laoshan District, Qingdao, Shandong
Attention: Inkon Life Technology Co.Ltd(300143) Hu Yuanyuan, Securities Department
Postal Code: 266103
Tel: 0532-55776787
Fax: 0532-55776787
Please properly seal all the documents submitted, indicate the contact number and contact person of the shareholder entrusted to vote, and indicate the words “power of attorney for public solicitation of entrusted voting rights by independent directors” in a prominent position.
Step 4: the witness lawyer shall confirm the valid votes.
The witness lawyer of the law firm hired by the company will conduct formal review on the documents listed above submitted by corporate shareholders and individual shareholders. The valid authorization confirmed by the audit will be submitted to the collector by the witness lawyer.
(V) after the documents submitted by the entrusted voting shareholders are delivered, the authorized entrustment that meets all the following conditions will be confirmed as valid:
1. The power of attorney and relevant documents have been delivered to the designated place in accordance with the requirements of the collection procedure of this report;
2. Submit the power of attorney and relevant documents within the collection time;
3. The shareholders have filled in and signed the power of attorney according to the format specified in the annex to this report, the content of the authorization is clear, and the relevant documents submitted are complete and effective;
4. The power of attorney and relevant documents submitted are consistent with the contents recorded in the register of shareholders.
(VI) if a shareholder entrusts his / her voting rights to the soliciter repeatedly, but the contents of the authorization are different, the last power of attorney signed by the shareholder is valid. If the signing time cannot be judged, the last power of attorney received is valid. You cannot vote on the same matter more than once. In case of multiple voting (including on-site voting, entrusted voting and online voting), the first voting result shall prevail.
(VII) after the shareholder entrusts the voting right of the solicitation to the soliciter, the shareholder may attend the meeting in person or by proxy.
(VIII) in case of any of the following circumstances in the confirmed valid authorization, the collector may deal with it in accordance with the following methods:
1. After the shareholder entrusts the voting right of the solicitation to the solicitor, and explicitly revokes the authorization to the solicitor in writing before the deadline of on-site meeting registration, the solicitor will deem that its authorization to the solicitor will automatically become invalid;
2. If the shareholder entrusts the voting right of the solicitation to someone other than the solicitor to register and attend the meeting, and expressly revokes the authorization to the solicitor in writing before the deadline of the on-site meeting registration, the solicitor will deem that its authorization to the solicitor will automatically become invalid;
3. The shareholders shall specify their voting instructions on the solicitation matters in the power of attorney submitted, and choose one of the consent, objection and waiver. If more than one is selected or not selected, the soliciter will deem its authorization invalid.
It is hereby announced.
Soliciter: Lu Jun attachment: power of attorney for public solicitation of voting rights of independent directors on January 11, 2022
enclosure:
Inkon Life Technology Co.Ltd(300143)
Power of attorney for public solicitation of voting rights by independent directors
I / the company, as the principal, confirm that I / we have carefully read the full text of the report on public solicitation of entrusted voting rights by Inkon Life Technology Co.Ltd(300143) independent directors prepared and announced by the collector for the solicitation of voting rights before signing this power of attorney
